Over the past 20 years, adeno-associated viruses (AAVs) have been extensively studied as potential gene therapy vectors to deliver corrective genes into cells or tissues of target organisms. AAVs belong to the genus Dependovirus of the family Parvoviridae and require a helper virus such as adenovirus or herpes virus to cause effective infection. The non-pathogenicity of AAVs and the ability to package and deliver foreign DNA to target cells make them ideal viral vectors for gene delivery. To date, 11 different serotypes have been found in primates, AAV serotypes 1 (AAV1) to AAV11, and many more recombinant isolates have been found in different tissues of humans and non-human primates.
AAV8 was isolated from rhesus macaque tissues and has a high degree of homology to other AAVs, but it has been reported to have a much higher hepatocyte transduction efficiency than all other AAVs tested to date. For example, in a mouse model, AAV8 has been reported to have a liver transduction efficiency that is approximately 50 times higher than that of AAV2. This observation, coupled with the low reactivity to human AAV antibodies, has led to efforts to develop AAV8 as a viral vector for liver-directed gene therapy applications. Long-term correction of hemophilia A, familial hypercholesterolemia, and glycogen storage disease type II using AAV8 as a gene therapy vector has been reported in mouse models. In addition, AAV8 has been successfully used for liver-directed gene therapy in canine models and has been shown to effectively cross the vascular barrier to achieve systemic gene transfer in skeletal and cardiac muscle in mice and hamsters.
Regulating neuro-metabolic-inflammatory responses is essential for maintaining physiological homeostasis. However, the molecular mechanisms that coordinate neural, metabolic, and inflammatory responses are largely unknown. Here, researchers show that semaphorin 6D (SEMA6D) coordinates anxiety, metabolic, and inflammatory outputs in the amygdala by maintaining synaptic homeostasis. Using a genome-wide approach, researchers identify SEMA6D as a pleiotropic gene underlying human psychiatric and metabolic traits. Sema6d deficiency increases anxiety in mice. When fed a high-fat diet, Sema6d−/− mice exhibit reduced adiposity and enhanced myelopoiesis compared with control mice, due to higher sympathetic activity through β3-adrenergic receptors. Genetic manipulations and spatial and single-nucleus transcriptomics reveal that SEMA6D in amygdala interneurons is responsible for regulating anxiety and autonomic responses. Mechanistically, SEMA6D is required for synaptic maturation and γ-aminobutyric acid transmission. These results suggest that SEMA6D is important for the normal functioning of the neural circuits in the amygdala, coupling emotional, metabolic, and inflammatory responses.
Here, to directly determine whether amygdalar SEMA6D is involved in the regulation of anxiety and systemic metabolism, researchers stereotaxically injected AAV8-hSyn-GFP or AAV8-hSyn-Cre-GFP into the CeA of Sema6dfl/fl mice. CeA-specific SEMA6D deletion reduced exploration time in the OF test and mitigated HFD-induced obesity, indicating that amygdala SEMA6D is responsible for the regulation of anxiety and systemic metabolism (Figures 1I-1K).
Figure 1. Sema6dfl/fl mice were bilaterally injected with AAV8-hSyn-GFP or AAV8-hSyn-Cre-GFP into the CeA. (Nakanishi Y, et al., 2024)
Customer Reviews
High-quality
After using Synapsin-GFP AAV (Serotype 8) in several rounds of experiments, I can confidently say that its performance is remarkably reliable.
Write a Review